Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jill Maaske"'
Autor:
David Benkeser, Youyi Fong, Holly E. Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule, Ann Marie Stanley, Jill Maaske, Tonya Villafana, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Victor Ayala, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Lindsay N. Carpp, April K. Randhawa, Michele P. Andrasik, James G. Kublin, Margaret Brewinski Isaacs, Mamodikoe Makhene, Tina Tong, Merlin L. Robb, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Corey Hoffman, Ann R. Falsey, Magdalena Sobieszczyk, Richard A. Koup, Ruben O. Donis, Peter B. Gilbert, on behalf of the AstraZeneca AZD1222 Clinical Study Group, the Immune Assays Team, the United States Government (USG)/CoVPN Biostatistics Team
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-13 (2023)
Abstract In the phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine conducted in the U.S., Chile, and Peru, anti-spike binding IgG concentration (spike IgG) and pseudovirus 50% neutralizing antibody titer (nAb ID50) measured four weeks after two d
Externí odkaz:
https://doaj.org/article/4081698c1e354ea79e55b3bd26cbe811
Autor:
Jill Maaske, Stephanie Sproule, Ann R. Falsey, Magdalena E. Sobieszczyk, Anne F. Luetkemeyer, Grant C. Paulsen, Sharon A. Riddler, Merlin L. Robb, Charlotte-Paige Rolle, Beverly E. Sha, Tina Tong, Bahar Ahani, Anastasia A. Aksyuk, Himanshu Bansal, Timothy Egan, Brett Jepson, Marcelino Padilla, Nirmeshkumar Patel, Kathryn Shoemaker, Ann Marie Stanley, Phillip A. Swanson, Deidre Wilkins, Tonya Villafana, Justin A. Green, Elizabeth J. Kelly
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundBreakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in coronavirus disease 2019 (COVID-19) vaccinees typically produces milder disease than infection in unvaccinated individuals.MethodsTo explore disease atte
Externí odkaz:
https://doaj.org/article/a7f99999dfa54de681877a3fca396db9
Autor:
Magdalena E. Sobieszczyk, Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck Jr., Hong-Van Tieu, Kenneth H. Mayer, Lawrence Corey, Kathleen M. Neuzil, Tina Tong, Margaret Brewinski Isaacs, Holly Janes, Himanshu Bansal, Lindsay M. Edwards, Justin A. Green, Elizabeth J. Kelly, Kathryn Shoemaker, Therese Takas, Tom White, Prakash Bhuyan, Tonya Villafana, and Ian Hirsch, on behalf of the AstraZeneca AZD1222 Clinical Study Group
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 18 (2022)
Background We report updated safety, efficacy, and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) from an ongoing phase 3 trial.Methods Adults at increased risk of SARS-CoV-2 infection were randomized (2:1), stratified by age, to receive 2 doses of AZD1
Externí odkaz:
https://doaj.org/article/0223bfbe518d427787c488021708dfaa
Autor:
Magdalena E Sobieszczyk, Ann R Falsey, Anne F Luetkemeyer, Grant C Paulsen, Sharon A Riddler, Merlin L Robb, Charlotte-Paige M Rolle, Beverly E Sha, Tina Tong, Bahar Ahani, Anastasia A Aksyuk, Himanshu Bansal, Justin A Green, Brett Jepson, Jill Maaske, Kathryn Shoemaker, Stephanie Sproule, Ann Marie Stanley, Deidre Wilkins, Tonya L Villafana, Elizabeth J Kelly
Publikováno v:
Open Forum Infectious Diseases. 9
Background Breakthrough infections post-COVID-19 vaccination increase with waning immunity and typically produce milder disease than infections in unvaccinated individuals. We investigated immuno-virologic responses and COVID-19 symptom burden upon b
Autor:
Juan P. Frias, Paul D. Hockings, Lars Johansson, Jill Maaske, Lisa J. Suchower, John P.H. Wilding, Nayyar Iqbal
Publikováno v:
Diabetes, Obesity and Metabolism. 24:61-71
AIM To report the results of a 104-week extension to a 52-week study in which dapagliflozin plus saxagliptin (DAPA+SAXA) improved glycaemic control, liver fat and metabolic variables compared with glimepiride (GLIM) in participants with type 2 diabet
Autor:
Anastasia A. Aksyuk, Himanshu Bansal, Deidre Wilkins, Ann Marie Stanley, Stephanie Sproule, Jill Maaske, Satya Sanikommui, William R. Hartman, Magdalena E. Sobieszczyk, Ann R. Falsey, Elizabeth J. Kelly
Publikováno v:
Cell reports. Medicine.
The nasal mucosa is an important initial site of host defense against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, intramuscularly administered vaccines typically do not achieve high antibody titers in the nasal mu
Autor:
Juan P. Frias, Donald C. Simonson, Marcia A. Testa, Guillermo Gonzalez‐Galvez, Anne L. Peters, Jill Maaske, Nalina Dronamraju, Eva Johnsson, Ricardo Garcia-Sanchez
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To evaluate the efficacy and safety of dapagliflozin (DAPA) + saxagliptin (SAXA) compared with glimepiride (GLIM) in patients with type 2 diabetes who were inadequately controlled [glycated haemoglobin (HbA1c) 7.5–10.5% (58–91 mmol/mol)] on
Autor:
Nalina Dronamraju, Paul D. Hockings, Lars Johansson, John P.H. Wilding, Jill Maaske, Eva Johnsson, Ricardo Garcia-Sanchez
Publikováno v:
Diabetes, Obesity & Metabolism
DIABETES OBESITY & METABOLISM
DIABETES OBESITY & METABOLISM
Aim To assess the effects of dapagliflozin plus saxagliptin plus metformin versus glimepiride plus metformin on liver fat (proton density fat fraction) and visceral and subcutaneous adipose tissue volumes over 52 weeks of treatment. Materials and met
Autor:
Ann R, Falsey, Magdalena E, Sobieszczyk, Ian, Hirsch, Stephanie, Sproule, Merlin L, Robb, Lawrence, Corey, Kathleen M, Neuzil, William, Hahn, Julie, Hunt, Mark J, Mulligan, Charlene, McEvoy, Edwin, DeJesus, Michael, Hassman, Susan J, Little, Barbara A, Pahud, Anna, Durbin, Paul, Pickrell, Eric S, Daar, Larry, Bush, Joel, Solis, Quito Osuna, Carr, Temitope, Oyedele, Susan, Buchbinder, Jessica, Cowden, Sergio L, Vargas, Alfredo, Guerreros Benavides, Robert, Call, Michael C, Keefer, Beth D, Kirkpatrick, John, Pullman, Tina, Tong, Margaret, Brewinski Isaacs, David, Benkeser, Holly E, Janes, Martha C, Nason, Justin A, Green, Elizabeth J, Kelly, Jill, Maaske, Nancy, Mueller, Kathryn, Shoemaker, Therese, Takas, Richard P, Marshall, Menelas N, Pangalos, Tonya, Villafana, Antonio, Gonzalez-Lopez, Barry S, Zingman
Publikováno v:
The New England Journal of Medicine
The New England journal of medicine, vol 385, iss 25
The New England journal of medicine, vol 385, iss 25
Background The safety and efficacy of the AZD1222 (ChAdOx1 nCoV-19) vaccine in a large, diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States, Chile, and Peru has not been
Autor:
null Juan P. Frías, null Jill Maaske, null Lisa Suchower, null Lars Johansson, null Paul D. Hockings, null Nayyar Iqbal, null John P. H. Wilding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a407ab76014abfb09b41de9ea5a516d6
https://doi.org/10.1111/dom.14548/v2/response1
https://doi.org/10.1111/dom.14548/v2/response1